Literature DB >> 17047730

Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice.

Andrew B Lassman1, Chengkai Dai, Gregory N Fuller, Andrew J Vickers, Eric C Holland.   

Abstract

The c-MYC protooncogene is overexpressed in the most malignant primary brain tumor, glioblastoma multiforme (GBM), and has been correlated with the undifferentiated character of several cell types. However, the role of Myc activity in the generation of GBMs is not known. In this report, we show that gene transfer of c-MYC to GFAP-expressing astrocytes in vitro promotes the outgrowth of GFAP-negative, nestin-expressing cells with progenitor-like morphology, growth characteristics and gene-expression pattern. In addition, gene transfer of c-MYC to GFAP-expressing astrocytes in vivo induces GBMs when co-expressed with activated Ras and Akt. Without c-MYC, Ras+Akt induces GBMs from nestin-expressing CNS progenitors but is insufficient in GFAP-expressing differentiated astrocytes. The ability of Myc activity to enhance the oncogenic effects of Ras+Akt appears to be limited to GFAP-expressing astrocytes because nestin-expressing progenitors show no increase in GBM formation with the addition of MYC to Ras+Akt. These studies indicate that one role of MYC activity in the formation of gliomas might be to either promote or reinforce an undifferentiated phenotype required for glioma cells to respond to the oncogenic effects of elevated Ras and Akt activity.

Entities:  

Year:  2004        PMID: 17047730      PMCID: PMC1615889          DOI: 10.1017/s1740925x04000249

Source DB:  PubMed          Journal:  Neuron Glia Biol        ISSN: 1740-925X


  17 in total

Review 1.  Gliogenesis in the central nervous system.

Authors:  J C Lee; M Mayer-Proschel; M S Rao
Journal:  Glia       Date:  2000-04       Impact factor: 7.452

2.  The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses.

Authors:  M Himly; D N Foster; I Bottoli; J S Iacovoni; P K Vogt
Journal:  Virology       Date:  1998-09-01       Impact factor: 3.616

3.  Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice.

Authors:  E C Holland; J Celestino; C Dai; L Schaefer; R E Sawaya; G N Fuller
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

Review 4.  Development of a flexible and specific gene delivery system for production of murine tumor models.

Authors:  G H Fisher; S Orsulic; E Holland; W P Hively; Y Li; B C Lewis; B O Williams; H E Varmus
Journal:  Oncogene       Date:  1999-09-20       Impact factor: 9.867

5.  Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma.

Authors:  J Trent; P Meltzer; M Rosenblum; G Harsh; K Kinzler; R Mashal; A Feinberg; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

6.  Reversible tumorigenesis by MYC in hematopoietic lineages.

Authors:  D W Felsher; J M Bishop
Journal:  Mol Cell       Date:  1999-08       Impact factor: 17.970

7.  Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene.

Authors:  K Ichimura; E E Schmidt; H M Goike; V P Collins
Journal:  Oncogene       Date:  1996-09-05       Impact factor: 9.867

8.  Quantification of the c-myc oncoprotein in human glioblastoma cells and tumor tissue.

Authors:  H H Engelhard; A B Butler; K D Bauer
Journal:  J Neurosurg       Date:  1989-08       Impact factor: 5.115

9.  The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors.

Authors:  J Schaefer-Klein; I Givol; E V Barsov; J M Whitcomb; M VanBrocklin; D N Foster; M J Federspiel; S H Hughes
Journal:  Virology       Date:  1998-09-01       Impact factor: 3.616

10.  A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice.

Authors:  E C Holland; W P Hively; R A DePinho; H E Varmus
Journal:  Genes Dev       Date:  1998-12-01       Impact factor: 11.361

View more
  22 in total

1.  Early progenitor cell marker expression distinguishes type II from type I focal cortical dysplasias.

Authors:  Ksenia A Orlova; Victoria Tsai; Marianna Baybis; Gregory G Heuer; Sanjay Sisodiya; Maria Thom; Kevin Strauss; Eleonora Aronica; Phillip B Storm; Peter B Crino
Journal:  J Neuropathol Exp Neurol       Date:  2010-08       Impact factor: 3.685

Review 2.  Brain tumor stem cells.

Authors:  Georgia Panagiotakos; Viviane Tabar
Journal:  Curr Neurol Neurosci Rep       Date:  2007-05       Impact factor: 5.081

Review 3.  The neurobiology of gliomas: from cell biology to the development of therapeutic approaches.

Authors:  Manfred Westphal; Katrin Lamszus
Journal:  Nat Rev Neurosci       Date:  2011-08-03       Impact factor: 34.870

4.  Off-target effect of the BMI1 inhibitor PTC596 drives epithelial-mesenchymal transition in glioblastoma multiforme.

Authors:  Anthony Flamier; Mohamed Abdouh; Rimi Hamam; Andrea Barabino; Niraj Patel; Andy Gao; Roy Hanna; Gilbert Bernier
Journal:  NPJ Precis Oncol       Date:  2020-01-06

Review 5.  Review: insights gained from modelling high-grade glioma in the mouse.

Authors:  S L Rankin; G Zhu; S J Baker
Journal:  Neuropathol Appl Neurobiol       Date:  2012-06       Impact factor: 8.090

6.  The Polycomb Repressive Complex 1 Protein BMI1 Is Required for Constitutive Heterochromatin Formation and Silencing in Mammalian Somatic Cells.

Authors:  Mohamed Abdouh; Roy Hanna; Jida El Hajjar; Anthony Flamier; Gilbert Bernier
Journal:  J Biol Chem       Date:  2015-10-14       Impact factor: 5.157

7.  NPAS3 demonstrates features of a tumor suppressive role in driving the progression of Astrocytomas.

Authors:  Frederico Moreira; Tim-Rasmus Kiehl; Kelvin So; Norbert F Ajeawung; Carmelita Honculada; Peter Gould; Russell O Pieper; Deepak Kamnasaran
Journal:  Am J Pathol       Date:  2011-05-19       Impact factor: 4.307

8.  Long-term exposure to imatinib reduced cancer stem cell ability through induction of cell differentiation via activation of MAPK signaling in glioblastoma cells.

Authors:  Yucui Dong; Qinglian Han; Yan Zou; Zhenling Deng; Xinliang Lu; Xiaohua Wang; Weihua Zhang; Hua Jin; Jun Su; Tao Jiang; Huan Ren
Journal:  Mol Cell Biochem       Date:  2012-07-25       Impact factor: 3.396

9.  Low Concentration Microenvironments Enhance the Migration of Neonatal Cells of Glial Lineage.

Authors:  Richard A Able; Celestin Ngnabeuye; Cade Beck; Eric C Holland; Maribel Vazquez
Journal:  Cell Mol Bioeng       Date:  2012-06       Impact factor: 2.321

Review 10.  miRNA-regulated cancer stem cells: understanding the property and the role of miRNA in carcinogenesis.

Authors:  Chiranjib Chakraborty; Kok-Yong Chin; Srijit Das
Journal:  Tumour Biol       Date:  2016-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.